SCHEMBL29672871

CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O

nearest known ligand 0.70

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	IL23R	Q5VWK5	10/20	0.70

▸	C5AR1	P21730	1/20	0.65

▸	NPY1R	P25929	1/20	0.64

▸	NPY2R	P49146	1/20	0.64

▸	NPY4R	P50391	1/20	0.64

▸	NPY5R	Q15761	1/20	0.64

▸	CXCR4	P61073	5/20	0.63

▸	GLP1R	P43220	2/20	0.59

▸	GIPR	P48546	2/20	0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29436331	0.97	IL23R (0.70)	IL23RC5AR1NPY1RNPY2RNPY4R
SCHEMBL30607479	0.92	NPY1R (0.68)	IL23RC5AR1NPY1RNPY2RNPY4R
SCHEMBL31182825	0.91	IL23R (0.65)	IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL38661970	0.90	IL23R (0.67)	IL23RC5AR1NPY1RNPY2RNPY4R
SCHEMBL30640750	0.89	CXCR4 (0.69)	IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30436762	0.89	IL23R (0.72)	IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30607276	0.89	C5AR1 (0.68)	IL23RC5AR1NPY1RNPY2RNPY4R
SCHEMBL31683367	0.89	CXCR4 (0.62)	IL23RC5AR1NPY1RNPY2RNPY4R
SCHEMBL29416039	0.89	CXCR4 (0.65)	IL23RC5AR1NPY1RNPY2RNPY4R
SCHEMBL30527936	0.89	CXCR4 (0.65)	IL23RC5AR1NPY1RNPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4025585-A1	MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE	Advanced technologies for novel therapeutics, LLC (US)	2022-07-13	—	—	EP	disclosed